| Literature DB >> 30966320 |
Arianna De Mori1, Marta Peña Fernández2, Gordon Blunn3, Gianluca Tozzi4, Marta Roldo5.
Abstract
Injuries of bone and cartilage constitute important health issues costing the National Health Service billions of pounds annually, in the UK only. Moreover, these damages can become cause of disability and loss of function for the patients with associated social costs and diminished quality of life. The biomechanical properties of these two tissues are massively different from each other and they are not uniform within the same tissue due to the specific anatomic location and function. In this perspective, tissue engineering (TE) has emerged as a promising approach to address the complexities associated with bone and cartilage regeneration. Tissue engineering aims at developing temporary three-dimensional multicomponent constructs to promote the natural healing process. Biomaterials, such as hydrogels, are currently extensively studied for their ability to reproduce both the ideal 3D extracellular environment for tissue growth and to have adequate mechanical properties for load bearing. This review will focus on the use of two manufacturing techniques, namely electrospinning and 3D printing, that present promise in the fabrication of complex composite gels for cartilage and bone tissue engineering applications.Entities:
Keywords: 3D printing; bone; cartilage; composite hydrogels; electrospinning
Year: 2018 PMID: 30966320 PMCID: PMC6414880 DOI: 10.3390/polym10030285
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Figure 1Schematic illustration of the basic setup for electrospinning. Reproduced from [62] with permission. Copyright (2015) Elsevier.
Figure 2Effect of increasing applied voltage on the shape of the solution drop ejected by the needle: (a) normal dripping; (b) micro dripping; (c) intermittent Taylor cone; and (d) Taylor cone jet.
Figure 3(a) Architectural framework of a native extracellular matrix (ECM); (b) electrospun 2D mat; (c) laminated hydrogel; and (d) fibres encapsulated into a hydrogel. Reproduced from [71] with permission. Copyright (2011) PMC.
Publications on electrospun fibres reinforced hydrogels for cartilage regeneration.
| Fibre(s) | Hydrogel | Fabrication method | Mechanical properties | Cytocompatibility | Reference |
|---|---|---|---|---|---|
| PCL or CSMA/PVAMA | PEG-diacrylate | Fibres mixed with the hydrogel | Not reported | Chondrogenic differentiation | [ |
| Polyacrylonitrile | Alginate-polyacrylamide | Sandwich-like structure | Young modulus: 3.4 MPa | Not reported | [ |
| PDLA/PLLA or PDLA/PCL | Chitosan | Fibre infiltrated with hydrogel | Compressive modulus: 2–12 MPa | Cartilage ECM deposition | [ |
| PCL | GelMA and GelMA/HAMA | Fibres infiltrated with hydrogels | Compressive modulus: 20–1500 kPa | Not reported | [ |
| PCL | PEG-heparin | Fibres infiltrated with hydrogel | Compressive modulus: 10–1500 kPa | Cell viability > 80% Chondrogenic differentiation | [ |
| PLA | Alginate-graft-hyaluronate | Hydrogel mixed fibres and gelled | Compressive modulus: 3–5.4 kPa | Cell viability > 85% Chondrogenic differentiation | [ |
| SIlk | Chitosan | Sandwich-like structure | Compressive modulus: 0.5–0.6 kPa | Cell viability > 90% Chondrogenic differentiation | [ |
| PCL | Alginate or alginate sulphate | Hydrogel pipetted onto the scaffolds | Shear modulus: 0.5–5 kPa | Cartilage ECM deposition | [ |
Figure 4Schematic overview of the method to fabricate 3D cell-laden laminated hydrogels. Reproduced from [69] with permission. Copyright (2016) Elsevier.
Figure 5Schematic of the steps for the formation of nanoyarns using a water vortex. Reproduced from [82] with permission. Copyright (2007) Elsevier.
Figure 6(A) SEM images of electrospun nanofiber mesh; (B) tubular implant without perforations; (C) tubular implant with perforations; (D) stabilized femur defect with implant; (E) bone defect, after placement of a perforated mesh tube; (F) alginate hydrogel was still present after 1 week, in vivo; and (G) release of rhBMP-2 from alginate hydrogel. Reproduced from [83] with permission. Copyright (2010) Elsevier.
Figure 7Illustration of 3D bioprinting technologies based on the mechanism used to assist the deposition of the bioinks and its main components; (Left) Inkjet bioprinters eject small droplets of cells and hydrogel sequentially to build up the scaffold; (Middle) Laser bioprinters use a laser to generate the local ejection of small droplets from a donor ribbon coated with the bioink; (Right) Extrusion bioprinters uses pneumatic of mechanical forces to continuously extrude the bioink through a nozzle. Reproduced from [100] with permission. Copyright (2015) Wiley-VCH.
Figure 8Schematic of the challenges for engineering bioinks suitable for 3D printing. Optimal shape fidelity can be typically achieved with stiff hydrogels (top right), however, this dense network limits cell viability. Contrarily, cell survive best in soft hydrogels, but shape fidelity cannot be achieved (bottom left). Therefore, a compromise between biological and fabrication properties must be done (middle). Novel strategies aimed at obtaining high shape fidelity with cytocompatible hydrogels. Reproduced from [105] with permission. Copyright (2009) Wiley-VCH.
Figure 93D printed constructs made of a composite hydrogel (alginate + nanofibrillated cellulose) seeded with human chondrocytes. (A) 3D printed small grids (7.2 × 7.2 mm2). Deformed grid during (B), and after (C) squeezing. (D) 3D printed human ear. (E, F) 3D printed sheep meniscus. Reproduced from [115] with permission Copyright (2015) American Chemical Society.
Figure 103D bio-printed constructs made of alginate/gelatin (AG) and alginate/gelatin/nano-HAp (AGH) mixed with human adipose-derived stem cells (hASCs) before and after implantation showing osteoinduction. Constructs were implanted into the back sub-cutaneous area of nude mice and harvested eight weeks after surgery. Larger bone formation was observed in the constructs containing HAp. Reproduced from [140] with permission, Copyright (2016) Royal Society of Chemistry.
Overview of publications on 3D printing of hydrogels for cartilage tissue engineering.
| Material(s) | Cell source(s) | Printing method | Mechanical properties | Cytocompatibility | Reference |
|---|---|---|---|---|---|
| Sodium alginate | ATDC5 chondrogenic cell line | Inkjet bioprinting | Compressive modulus: 20–70 kPa | ~85% cell viability Cartilage ECM deposition | [ |
| Alginate with cellulose nanofibers | Human nasoseptal chondrocytes | Inkjet bioprinting | Compressive modulus: 75–250 kPa | 73–86% cell viability | [ |
| Alginate with cellulose nanofibers | Human nasoseptal chondrocytes | Extrusion bioprinting | Compressive stress: 15–88 kPa | Cartilage ECM deposition | [ |
| Alginate with cellulose nanofibers | Human nasoseptal chondrocytes and MSCs | Extrusion bioprinting | Not reported | Chondrogenic differentiation Chondrocytes proliferation | [ |
| Alginate with gellan | Bovine articular chondrocytes | Extrusion bioprinting | Tensile modulus: 116–230 kPa | 80–96% cell viability. Cartilage ECM deposition Chondrocytes proliferation | [ |
| Methacrylated HA with diacrylated Pluronic | Bovine articular chondrocytes | Inkjet bioprinting | Compressive modulus: 1.5–6.5 kPa | 62–86% cell viability | [ |
| HA with dextran derived | Equine articular chondrocytes | Extrusion bioprinting | Ultimate compressive stress: 100–160 kPa | >75% cell viability | [ |
| GelMA with HA | Equine articular chondrocytes | Inkjet bioprinting | Compressive modulus: 5–180 kPa | >73% cell viability | [ |
| GelMA with HA-methacrylate | Human bone marrow MSCs | Extrusion bioprinting | Compressive modulus: 48–100 kPa | 85–95% cell viability.Chondrogenic differentiation | [ |
| GelMA | Equine ACPCs/Chondrocytes/MSCs | Inkjet bioprinting | Compressive modulus: 100–187 kPa | >75% cell viability | [ |
| PEGDMA | Human articular chondrocytes | Inkjet bioprinting | Compressive modulus: ~400 kPa | 89% cell viability Cartilage ECM deposition | [ |
| PEG-GelMA | Human MSCs | Inkjet bioprinting | Compressive modulus: ~1 MPa | ~80% cell viability Cartilage ECM deposition Chondrogenic differentiation | [ |
| Alginate reinforced with PCL | Embryonic chick chondrocytes | Extrusion bioprinting | Not reported | 77–85% cell viability Cartilage ECM deposition | [ |
| Alginate reinforced with PCL + TGFβ | Human nososeptal chondrocytes | Extrusion bioprinting | Not reported | 85% cell viability Cartilage ECM deposition | [ |
| Alginate reinforced with PCL | C20A4 human chondrocyte cell line | Extrusion bioprinting | Compressive modulus: 6 MPa | ~70% cell viability | [ |
Overview of publications on 3D printing of hydrogels for bone tissue engineering.
| Material(s) | Cell source(s) | Printing method | Mechanical properties | Cytocompatibility | Reference |
|---|---|---|---|---|---|
| MeHA | Human BM MSCs | Inkjet bioprinting | Elastic modulus: ~11 kPa | ~65% cell viability Osteogenic differentiation | [ |
| Agarose with collagen type I | Human BM MSCs | Inkjet bioprinting | Compressive modulus: 18–90 kPa | >98% cell viability Osteogenic differentiation | [ |
| Alginate-gelatin | hASCs | Inkjet bioprinting | Not reported | Osteogenic differentiation Bone matrix formation | [ |
| Chitosan-HAp | Human osteoblasts | Extrusion printing | Not reported | Good cell attachment and proliferation | [ |
| Chitosan-HAp/Alginate-HAp | MC3T3-E1 | Inkjet bioprinting | Elastic modulus: 4.6–15 kPa/3.5–19 kPa | >90% cell viability Cell proliferation Osteogenic differentiation | [ |
| MeHA with HAp or GelMA with HAp | hASCs | Extrusion bioprinting | Not reported | Osteogenic differentiation Bone matrix formation | [ |
| Alginate-gelatin/alginate-gelatin with nano-HAp | hASCs | Extrusion bioprinting | Not reported | >88% cell viability Osteogenic differentiation | [ |
| Alginate-polyvinyl alcohol with HAp | MC3T3-E1 cells | Extrusion bioprinting | Compressive modulus: 2.4–10.3 kPa | 77–95% cell viability | [ |
| Chitosan reinforced with PCL | Rabbit BM MSCs | Extrusion bioprinting | Compressive strength: 6.7 MPa | Osteogenic differentiation Bone matrix formation | [ |
| HA and Gelatin reinforced with PCL/TCP | Human amniotic fluid-SCs | Extrusion bioprinting | Not reported | 91% cell viability Osteogenic differentiation Bone matrix formation | [ |
| MeHA and GelMA reinforced with PCL/HAp | Stromal vascular fraction derived cells | Extrusion bioprinting | Not reported | Osteogenic differentiation | [ |